Antimicrobial Resistance: Where to from Here?

Conclusion Newer tools capable of informing these early decisions are under development, but integrating an awareness of AMR into both hospital and GP practice is a key component of winning the fight against superbugs. Throughout the development process, discussion between clinicians and researchers will ensure that diagnostic tools are effective, and also meet the needs of frontline staff. In the mean-time, cultivating an AMR aware mind-set is the best defence against over-prescription. Understanding and accepting the systematic, ubiquitous biases which affect our judgement of risk is particularly helpful. For example, doctors are expected to protect both individual and public health; roles which sometimes conflict when prescribing antibiotics. Developing the tendency to take pause and consider whether antibiotics are necessary is a simple yet powerful action which can reduce the chances of over-prescription in both the GP clinic and hospital settings. References: Hall, JM, Ingram, PR, O’Reilly, LC &Inglis, TJJ 2016, ‘Temporal Flux in Beta-Lactam Resistance among Klebsiella pneumoniae in Western Australia.’, Journal of Medical Microbiology, vol. 65, no. 5, pp. 429–437. Mulroney, KT, Hall, JM, Huang, X, Turnbull, E, Bzdyl, NM, Chakera, A, Naseer, U, Corea, EM, Ellington, MJ, Hopkins, KL, Wester, AL, Ekelund, O, Woodford, N, &Inglis, TJJ 2017, ‘Rapid susceptibility profiling of carbapenem-resistant Klebsiella pneumoniae’, Scientifi...
Source: Life in the Fast Lane - Category: Emergency Medicine Authors: Tags: Clinical Research Microbiology AMR Antimicrobial resistance ESBL MROs multi-resistant organisms multidrug resistant organisms (MROs) Source Type: blogs

Related Links:

CONCLUSION: Prevalence of antibiotic use was high not only versus other hospitals in the region but globally including Africa, coupled with significant evidence of sub-optimal prescribing. Swift action is needed to improve future prescribing to reduce AMR. One or two areas should initially be targeted for quality improvement including development of local guidelines, documentation of antibiotic indications and/or stop/review dates. PMID: 33034234 [PubMed - as supplied by publisher]
Source: Expert Review of Anti-Infective Therapy - Category: Infectious Diseases Tags: Expert Rev Anti Infect Ther Source Type: research
Authors: Reissier S, Cattoir V Abstract INTRODUCTION: Streptogramins (pristinamycin and quinupristin-dalfopristin) can be interesting options for the treatment of infections due to Gram-positive cocci, especially multidrug-resistant isolates. AREAS COVERED: This review provides an updated overview on structural and activity characteristics, mechanisms of action and resistance, pharmacokinetic/pharmacodynamic and clinical use of streptogramins. EXPERT OPINION: The streptogramin antibiotics act by inhibition of the bacterial protein synthesis. They are composed of two chemically distinct compounds, namely typ...
Source: Expert Review of Anti-Infective Therapy - Category: Infectious Diseases Tags: Expert Rev Anti Infect Ther Source Type: research
Publication date: 15 February 2021Source: Journal of Hazardous Materials, Volume 404, Part BAuthor(s): Yanhua Liu, Yang Li, Shanshan Dong, Lu Han, Ruixin Guo, Yourong Fu, Shenghu Zhang, Jianqiu Chen
Source: Journal of Hazardous Materials - Category: Environmental Health Source Type: research
Authors: Musio F Abstract INTRODUCTION: Anemia has and will continue to be a central theme in medicine particularly as clinicians are treating a burgeoning population of complex multi-organ system processes. As a result of multiple randomized controlled trials (RCTs), meta-analyses, and societal recommendations overly restrictive paradigms and under-administration of erythropoiesis stimulating agents (ESAs) have likely been followed by clinicians among all specialties. AREAS COVERED: A review of anemia in the context of chronic kidney disease, hematologic malignancies and cancer is presented with focus on the e...
Source: Expert Review of Hematology - Category: Hematology Tags: Expert Rev Hematol Source Type: research
Publication date: January 2021Source: Urology Case Reports, Volume 34Author(s): Nina Al-Saadi, Safa Al-Musawi, Yousuf Khan, Daben Dawam
Source: Urology Case Reports - Category: Urology & Nephrology Source Type: research
Publication date: Available online 10 October 2020Source: European Journal of Surgical OncologyAuthor(s): Tetsutaro Miyoshi, Satoshi Yamaguchi, Hiroshi Fujimoto, Shigeru Yoshioka, Masayuki Shiobara, Kazuo Wakatsuki, Kosuke Suda, Kotaro Miyazawa, Toshiaki Aida, Yoshihiro Watanabe, Masayuki Ohtsuka
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research
Authors: Matti B, Zargar-Shoshtari K Abstract Prostate cancer represents a significant health burden worldwide. The cancer incidence had substantially increased since the introduction of prostate specific antigen (PSA) in cancer screening. This had led to considerable debates among health professionals and epidemiologists, since PSA as a screening tool seemed to be far from perfect. In New Zealand, the controversy was quite prominent in the last three decades, with some advocating the benefits of screening, while others concerned regarding the risk of harms. With the absence of an organised screening programme and ...
Source: New Zealand Medical Journal - Category: General Medicine Tags: N Z Med J Source Type: research
CONCLUSION: This study found that childhood cancer survivors in New Zealand had a high prevalence of developmental dental abnormalities and it identified potential risk factors related to their cancer treatment. Inequitable access to oral rehabilitation for this patient group argues for a mechanism for consistent improved access to publicly funded dental care across district health boards in New Zealand. PMID: 33032302 [PubMed - in process]
Source: New Zealand Medical Journal - Category: General Medicine Tags: N Z Med J Source Type: research
Authors: Zarrabi A, Mark S PMID: 33032299 [PubMed - in process]
Source: New Zealand Medical Journal - Category: General Medicine Tags: N Z Med J Source Type: research
Authors: Peng C, Cohen DJ Abstract INTRODUCTION: Esophageal squamous cancer remains an important cause of mortality worldwide with two new immunotherapy drugs recently approved for metastatic disease. AREAS COVERED: The authors review the epidemiology and genomics of esophageal squamous cell carcinoma. They also examine prior trials involving targeted agents under investigation as well immunotherapies that have been approved and novel combinations. EXPERT OPINION: Great advances have been made in characterizing the molecular changes in esophageal carcinoma. However, relatively few drugs have shown benefit i...
Source: Expert Opinion on Pharmacotherapy - Category: Drugs & Pharmacology Tags: Expert Opin Pharmacother Source Type: research
More News: Antimicrobial Resistance | Blogging | Cancer | Cancer & Oncology | Ceftriaxone | Chemotherapy | Clostridium Difficile | Education | Emergency Medicine | Epidemiology | Health Management | Infectious Diseases | International Medicine & Public Health | Men | Meningitis | Microbiology | Multidrug Resistance | Nurses | Nursing | Outbreaks | Rocephin | Study | Superbugs | Universities & Medical Training